Percentage of total radioactivity bound to 51Cr-labeled RBC-derived vesicles with or without hemoglobin
. | Percentage injected dose . |
|---|---|
| All vesicles | 100 |
| RBC-derived vesicles | 82* |
| RBC-derived vesicles + hemoglobin | 54† |
. | Percentage injected dose . |
|---|---|
| All vesicles | 100 |
| RBC-derived vesicles | 82* |
| RBC-derived vesicles + hemoglobin | 54† |
Calculated from percentage HIS49+ vesicles (21%) and 51Cr-binding ratio of RBC-derived and platelet-derived vesicles (16.7 : 1), assuming that non-RBC-derived vesicles in the rat are platelet-derived (79%): 21/79 × 16.7/1 = 4.43/1 → 4.43/(4.43 + 1) = 81.6%
Calculated from percentage of hemoglobin-containing RBC-derived vesicles (66%): 0.66 × 81.6 = 53.8%